Danesi, R <br/><br/>
Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS 201-995).  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Feb 1997 
 - 265-72 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Aorta<br/>Cell Division--drug effects<br/>Cells, Cultured<br/>Chick Embryo<br/>Chickens<br/>Cornea--blood supply<br/>Culture Media, Conditioned--pharmacology<br/>Drug Interactions<br/>Drug Screening Assays, Antitumor<br/>Female<br/>Fibrin--physiology<br/>Fibronectins--physiology<br/>Humans<br/>Mesentery--blood supply<br/>Neovascularization, Pathologic--prevention & control<br/>Octreotide--pharmacology<br/>Rats<br/>Rats, Wistar<br/>Somatostatin<br/>Tumor Cells, Cultured<br/>p-Methoxy-N-methylphenethylamine--pharmacology